Aortic Stenosis Market is Anticipated to Witness High Growth Owing to Growing Geriatric Population


 The aortic stenosis market is characterized by the increasing demand for aortic stenosis diagnostic and treatment methods. Aortic stenosis, also known as aortic valve stenosis, refers to the narrowing of the aortic valve opening, which hampers the normal flow of blood from the left ventricle to the aorta. It develops when calcium deposits harden and thicken the aortic valve tissues, preventing the valve leaflets from opening fully. The condition commonly affects older adults aged 65 and over. Some of the key symptoms include dizziness, fatigue, chest pain, fainting, and shortness of breath.


The rising prevalence of calcific aortic valve disease due to the growing geriatric population is a key factor driving the demand for aortic stenosis management. As per the estimates, about 2-7% of the people aged over 65 are affected by significant aortic stenosis. Moreover, the condition is more prevalent in males than females. Transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) have emerged as the preferred treatment options for severe symptomatic aortic stenosis. TAVR in particular is registering increased adoption globally owing to its minimally invasive nature.

The Global aortic stenosis market is estimated to be valued at US$ 8.33 Bn in 2024 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the aortic stenosis market are Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomédica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc. The market is highly competitive due to continuous product innovations.

TAVR has emerged as a promising alternative treatment approach to SAVR and the market for transcatheter valves and delivery systems is expected to witness robust growth over the forecast period. Rapidly growing public awareness about aortic stenosis and available treatment options also bode well for market expansion.

North America currently dominates the global aortic stenosis market. However, Asia Pacific region is anticipated to witness the fastest growth owing to rising healthcare investments and increasing demand for advanced surgical and transcatheter treatment procedures in emerging countries like India and China. Players are focusing on establishing manufacturing and distribution networks in Asia and other developing regions to tap into high growth opportunities.

Market Drivers
Rising Geriatric Population
The risk of developing aortic stenosis increases with age. According to the United Nations, over 16% of the global population will be aged 65 years and over by 2050. This demographic shift towards an aging society is expected to significantly drive the demand for aortic stenosis diagnostic tests and treatments.

Increasing Access to Advanced Care
Growing public awareness about available treatment options for aortic stenosis along with rising healthcare expenditures globally have positively impacted early diagnosis and access to minimally invasive and advanced surgical care. This is expected to boost the growth of the aortic stenosis market.

Market Restraints
High Cost of TAVR Procedures
While TAVR has emerged as a popular alternative to SAVR for high-risk patients, the associated treatment and device costs are relatively high compared to conventional surgical valve replacement. Limited reimbursement coverage in some countries poses affordability challenges, hampering faster market growth.

Stringent Regulatory Environment
New market entrants face stringent regulatory approval processes for novel aortic stenosis treatment technologies and devices. Significant investments are required towards clinical trials and obtaining regulatory clearances, which can delay market entry and commercialization plans of emerging players to some extent.

Segment Analysis

The aortic stenosis market is dominated by the transcatheter aortic valve replacement (TAVR) sub segment. TAVR procedures are preferred over open-heart surgical aortic valve replacement (SAVR) as they are minimally invasive and have a shorter recovery time. TAVR procedures do not require opening the chest or placing the patient on cardiopulmonary bypass. This has allowed TAVR treatment to be applied for high-risk or inoperable patients who were not candidates for conventional SAVR. The advantages of TAVR over SAVR continue to drive the growth of the TAVR sub segment and its increased domination of the aortic stenosis market.

Global Analysis

Geographically, the North America region currently dominates the aortic stenosis market and is expected to continue this trend over the forecast period. This is due to factors such as the rising geriatric population, growing prevalence of aortic valve stenosis, technological advancements, favorable reimbursement policies, and presence of leading market players in the region. Meanwhile, the Asia Pacific region is projected to witness the highest growth rate during the forecast period. Rapidly developing healthcare infrastructure, growing medical tourism industry, rising healthcare spending, and improving access to insurance are some key factors fueling the growth of the aortic stenosis market in this region.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more